Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMC 2737927)

Published in Appl Environ Microbiol on June 26, 2009

Authors

Máire Begley1, Paul D Cotter, Colin Hill, R Paul Ross

Author Affiliations

1: Department of Microbiology, University College Cork, Cork, Ireland.

Articles citing this

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol (2012) 2.76

Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc Natl Acad Sci U S A (2010) 2.18

BAGEL2: mining for bacteriocins in genomic data. Nucleic Acids Res (2010) 2.08

Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother (2010) 1.78

Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol (2010) 1.74

Genome mining for ribosomally synthesized natural products. Curr Opin Chem Biol (2010) 1.58

Lantibiotics from Geobacillus thermodenitrificans. Proc Natl Acad Sci U S A (2012) 1.53

Expansion of ribosomally produced natural products: a nitrile hydratase- and Nif11-related precursor family. BMC Biol (2010) 1.49

Structural Characterization and Bioactivity Analysis of the Two-Component Lantibiotic Flv System from a Ruminant Bacterium. Cell Chem Biol (2016) 1.45

Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A (2012) 1.44

Primer on agar-based microbial imaging mass spectrometry. J Bacteriol (2012) 1.22

Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria. PLoS One (2011) 1.11

The abi proteins and their involvement in bacteriocin self-immunity. J Bacteriol (2010) 1.08

In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics (2010) 1.04

Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters. PLoS One (2011) 1.01

Complete genome sequence of the filamentous gliding predatory bacterium Herpetosiphon aurantiacus type strain (114-95(T)). Stand Genomic Sci (2011) 0.99

Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity. Appl Environ Microbiol (2014) 0.95

Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria. BMC Genomics (2014) 0.93

Structural investigation of ribosomally synthesized natural products by hypothetical structure enumeration and evaluation using tandem MS. Proc Natl Acad Sci U S A (2014) 0.92

Automated genome mining of ribosomal peptide natural products. ACS Chem Biol (2014) 0.91

The orphan histidine protein kinase SgmT is a c-di-GMP receptor and regulates composition of the extracellular matrix together with the orphan DNA binding response regulator DigR in Myxococcus xanthus. Mol Microbiol (2012) 0.91

Restoration of bioactive lantibiotic suicin from a remnant lan locus of pathogenic Streptococcus suis serotype 2. Appl Environ Microbiol (2013) 0.90

Bovicin HJ50-like lantibiotics, a novel subgroup of lantibiotics featured by an indispensable disulfide bridge. PLoS One (2014) 0.90

Assessment of the bacteriocinogenic potential of marine bacteria reveals lichenicidin production by seaweed-derived Bacillus spp. Mar Drugs (2012) 0.88

Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in actinobacteria. Appl Environ Microbiol (2015) 0.86

Novel LanT associated lantibiotic clusters identified by genome database mining. PLoS One (2014) 0.85

Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens. Front Microbiol (2016) 0.85

Lessons learned from the transformation of natural product discovery to a genome-driven endeavor. J Ind Microbiol Biotechnol (2013) 0.83

Homologues and bioengineered derivatives of LtnJ vary in ability to form D-alanine in the lantibiotic lacticin 3147. J Bacteriol (2011) 0.83

Investigating the importance of charged residues in lantibiotics. Bioeng Bugs (2011) 0.82

In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database. BMC Microbiol (2015) 0.82

Some (bacilli) like it hot: genomics of Geobacillus species. Microb Biotechnol (2014) 0.81

Gene cluster analysis for the biosynthesis of elgicins, novel lantibiotics produced by Paenibacillus elgii B69. BMC Microbiol (2012) 0.81

Isolation and structure determination of a new lantibiotic cinnamycin B from Actinomadura atramentaria based on genome mining. J Ind Microbiol Biotechnol (2016) 0.80

Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity. Microb Biotechnol (2013) 0.79

Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides. Appl Environ Microbiol (2015) 0.79

Fermentation stage-dependent adaptations of Bacillus licheniformis during enzyme production. Microb Cell Fact (2013) 0.78

Distribution and Genetic Diversity of Bacteriocin Gene Clusters in Rumen Microbial Genomes. Appl Environ Microbiol (2015) 0.78

Using the overlay assay to qualitatively measure bacterial production of and sensitivity to pneumococcal bacteriocins. J Vis Exp (2014) 0.78

Substrate specificity of the lanthipeptide peptidase ElxP and the oxidoreductase ElxO. ACS Chem Biol (2014) 0.77

Improved antimicrobial activities of synthetic-hybrid bacteriocins designed from enterocin E50-52 and pediocin PA-1. Appl Environ Microbiol (2014) 0.76

Detection of putative new mutacins by bioinformatic analysis using available web tools. BioData Min (2011) 0.76

Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes. Chem Rev (2017) 0.75

Identification and classification of known and putative antimicrobial compounds produced by a wide variety of Bacillales species. BMC Genomics (2016) 0.75

Impact of domestication in the production of the class II lanthipeptide lichenicidin by Bacillus licheniformis I89. Curr Microbiol (2014) 0.75

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

Bacteriocins: developing innate immunity for food. Nat Rev Microbiol (2005) 5.77

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science (1999) 5.30

Biosynthesis and mode of action of lantibiotics. Chem Rev (2005) 4.59

Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol (2007) 4.00

Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol (2005) 3.87

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem (2000) 3.65

Lipid II as a target for antibiotics. Nat Rev Drug Discov (2006) 3.01

Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147. Mol Microbiol (1998) 2.61

The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol (2006) 2.53

Role of conjugative elements in the evolution of the multidrug-resistant pandemic clone Streptococcus pneumoniaeSpain23F ST81. J Bacteriol (2008) 2.51

An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol (1996) 2.45

Complete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus species. Genome Biol (2004) 2.41

Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci (2005) 2.21

Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci U S A (2006) 2.19

Genome and proteome of long-chain alkane degrading Geobacillus thermodenitrificans NG80-2 isolated from a deep-subsurface oil reservoir. Proc Natl Acad Sci U S A (2007) 2.06

Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem (1986) 2.04

Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur J Biochem (1992) 1.94

Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek (1996) 1.88

Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie (2002) 1.85

Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85

Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol (2000) 1.81

Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5. Antimicrob Agents Chemother (2005) 1.79

Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl Environ Microbiol (1999) 1.66

BAGEL: a web-based bacteriocin genome mining tool. Nucleic Acids Res (2006) 1.64

Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry (2004) 1.61

Characterization, distribution, and expression of novel genes among eight clinical isolates of Streptococcus pneumoniae. Infect Immun (2006) 1.55

Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci (2005) 1.54

Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans. FEBS Lett (1997) 1.52

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol (2006) 1.45

Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl Environ Microbiol (2003) 1.38

Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. J Antimicrob Chemother (1998) 1.37

Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl Environ Microbiol (1993) 1.36

Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother (2004) 1.35

Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology (2001) 1.34

Multiple activities in lantibiotics--models for the design of novel antibiotics? Curr Pharm Des (2002) 1.32

Molecular characterization of the Enterococcus faecalis cytolysin activator. Infect Immun (1991) 1.30

Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29

The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol (2003) 1.29

Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem (2007) 1.26

Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett Appl Microbiol (1999) 1.21

Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett (2007) 1.21

Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol Lett (2005) 1.19

Ribosomally synthesized antibacterial peptides in Gram positive bacteria. Curr Drug Targets (2002) 1.15

A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes. Dev Biol Stand (1995) 1.09

Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology (2000) 1.08

In vivo activity of mutacin B-Ny266. J Antimicrob Chemother (2005) 1.08

Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics. Eur J Biochem (2000) 0.99

A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry (2007) 0.95

Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8. Microbiology (2007) 0.92

Characterization of the gene cluster involved in the biosynthesis of macedocin, the lantibiotic produced by Streptococcus macedonicus. FEMS Microbiol Lett (2007) 0.84

Articles by these authors

Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94

Bacteriocins: developing innate immunity for food. Nat Rev Microbiol (2005) 5.77

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02

Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One (2009) 4.93

Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res (2010) 4.17

The interaction between bacteria and bile. FEMS Microbiol Rev (2005) 3.86

Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiol Mol Biol Rev (2003) 3.54

Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence. FEMS Microbiol Rev (2002) 3.40

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A (2007) 3.32

Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev (2010) 3.30

Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol (2012) 2.76

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A (2008) 2.53

The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol (2006) 2.53

Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut (2012) 2.24

Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci (2005) 2.21

Bile salt hydrolase activity in probiotics. Appl Environ Microbiol (2006) 2.19

Genome sequence of Lactobacillus helveticus, an organism distinguished by selective gene loss and insertion sequence element expansion. J Bacteriol (2007) 2.15

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A (2010) 2.11

The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes. FEBS Lett (2004) 1.93

Contribution of three bile-associated loci, bsh, pva, and btlB, to gastrointestinal persistence and bile tolerance of Listeria monocytogenes. Infect Immun (2005) 1.90

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A (2010) 1.89

Tools for functional postgenomic analysis of listeria monocytogenes. Appl Environ Microbiol (2008) 1.78

A PrfA-regulated bile exclusion system (BilE) is a novel virulence factor in Listeria monocytogenes. Mol Microbiol (2005) 1.74

High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother (2012) 1.69

The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol (2008) 1.62

Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry (2004) 1.61

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio (2012) 1.59

Bacteriocin production: a probiotic trait? Appl Environ Microbiol (2011) 1.57

Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol (2013) 1.56

Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol (2007) 1.54

Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes. PLoS Pathog (2008) 1.53

The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes (2012) 1.52

Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes. Appl Environ Microbiol (2006) 1.50

Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev (2009) 1.48

Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol (2010) 1.48

Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46

Bile stress response in Listeria monocytogenes LO28: adaptation, cross-protection, and identification of genetic loci involved in bile resistance. Appl Environ Microbiol (2002) 1.46

Multiple deletions of the osmolyte transporters BetL, Gbu, and OpuC of Listeria monocytogenes affect virulence and growth at high osmolarity. Appl Environ Microbiol (2002) 1.46

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol (2006) 1.45

Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol (2011) 1.42

The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Agents Chemother (2002) 1.41

A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol (2007) 1.38

Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases. Mar Drugs (2011) 1.36

Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol (2011) 1.34

Bacteriophage-resistance systems in dairy starter strains: molecular analysis to application. Antonie Van Leeuwenhoek (2002) 1.34

Disruption of putative regulatory loci in Listeria monocytogenes demonstrates a significant role for Fur and PerR in virulence. Infect Immun (2004) 1.34

The CtsR regulator of Listeria monocytogenes contains a variant glycine repeat region that affects piezotolerance, stress resistance, motility and virulence. Mol Microbiol (2003) 1.33

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J Med Microbiol (2007) 1.33

Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar Biotechnol (NY) (2008) 1.30

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother (2005) 1.30

The interaction between Listeria monocytogenes and the host gastrointestinal tract. Microbiology (2009) 1.29

Discovery of medically significant lantibiotics. Curr Drug Discov Technol (2009) 1.29

AgrD-dependent quorum sensing affects biofilm formation, invasion, virulence and global gene expression profiles in Listeria monocytogenes. Mol Microbiol (2009) 1.29

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol (2007) 1.27

A postgenomic appraisal of osmotolerance in Listeria monocytogenes. Appl Environ Microbiol (2003) 1.26

Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol (2008) 1.26

Molecular characterization of the arginine deiminase system in Listeria monocytogenes: regulation and role in acid tolerance. Environ Microbiol (2009) 1.26

Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem (2007) 1.26

Comparative genomics of lactic acid bacteria reveals a niche-specific gene set. BMC Microbiol (2009) 1.24

Molecular and physiological analysis of the role of osmolyte transporters BetL, Gbu, and OpuC in growth of Listeria monocytogenes at low temperatures. Appl Environ Microbiol (2004) 1.24

Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl Environ Microbiol (2005) 1.24

Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes (2012) 1.23

High-throughput sequencing for detection of subpopulations of bacteria not previously associated with artisanal cheeses. Appl Environ Microbiol (2012) 1.23

Presence of GadD1 glutamate decarboxylase in selected Listeria monocytogenes strains is associated with an ability to grow at low pH. Appl Environ Microbiol (2005) 1.22